Wyeth Consumer Healthcare Canadian Response to Robitussin U.S. Product Voluntary Recall

    MISSISSAUGA, ON, Oct. 30 /CNW/ - On October 29th, 2007, Wyeth Consumer
Healthcare in the United States announced a voluntary recall and replacement
program from the U.S. market of several Robitussin(R) products and Children's
Dimetapp(R) Cold & Chest Congestion. The products are being recalled and
replaced because the dosage cup with these products does not have a
half-teaspoon mark corresponding with their product labels. This action is
specific to the dosage cup and not related to the safety of the medication.
    The dosing cups in question are not included with any Robitussin(R) or
Dimetapp(R) products in Canada.
    Wyeth Consumer Healthcare Canada wants to assure consumers that they can
continue to use Robitussin(R) or Dimetapp(R) products. These products are safe
when used according to label directions.

For further information:

For further information: For media inquiries, please contact: Dr. Murray
Brown, Vice-President, Scientific Affairs, Wyeth Consumer Healthcare, Canada,
Tel: (905) 507-7055 or Dr. Walid Aldoori, Medical Director, Scientific
Affairs, Wyeth Consumer Healthcare, Canada, Tel: (905) 507-7098

Organization Profile


More on this organization


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890